Impact of the longitudinal evolution of impaired fasting glucose on cardio-kidney-metabolic multimorbidity - Takeaways - MDSpire

Impact of the longitudinal evolution of impaired fasting glucose on cardio-kidney-metabolic multimorbidity

  • By

  • Guanlin Chen

  • Hong Zheng

  • Yuxian Wang

  • Man Gui

  • Zhen He

  • Zekai Chen

  • Shouling Wu

  • Youren Chen

  • June 16, 2026

  • 0 min

Share

  • 1

    The study analyzed 43,073 adults to assess the impact of impaired fasting glucose (IFG) on cardio-kidney-metabolic multimorbidity risk.

  • 2

    Over 11 years, 1,795 participants developed multimorbidity, with persistent IFG showing the highest risk compared to sustained normal fasting glucose.

  • 3

    IFG recovery was associated with a lower risk of multimorbidity than progression or persistence, but still higher than those with sustained normal glucose.

  • 4

    The findings emphasize the importance of preventing IFG onset and timely intervention to reduce long-term multisystem health damage.

  • 5

    The study highlights the need for ongoing monitoring of cardio-kidney-metabolic risks even after apparent glycemic recovery.

Original Source(s)

Impact of the longitudinal evolution of impaired fasting glucose on cardio-kidney-metabolic multimorbidity

  • by Guanlin Chen, Hong Zheng, Yuxian Wang, Man Gui, Zhen He, Zekai Chen, Shouling Wu, Youren Chen

  • June 16, 2026

Related Content

AI Boosts Diabetic Eye Care Access

Recent study highlights how integrated AI-assisted DR screening in primary care clinics can improve access and decrease disparity

  • May 5, 2026

  • 3 min
From risk factors to molecular targets: clinical associations and molecular docking insights into phthalate-associated diabetic retinopathy

Assessment of Two-Phase Diagnostic Timelines in Diabetic Retinopathy and Contributing Factors: A Cross-Sectional Analysis